Nikhil Lalwani
2020
In 2020, Nikhil Lalwani earned a total compensation of $3.7M as President and Chief Executive Officer at ANI Pharmaceuticals.
Compensation breakdown
| Bonus | $210,000 |
|---|---|
| Option Awards | $2,479,073 |
| Salary | $199,231 |
| Stock Awards | $826,732 |
| Total | $3,715,036 |
Lalwani received $2.5M in option awards, accounting for 67% of the total pay in 2020.
Lalwani also received $210K in bonus, $199.2K in salary and $826.7K in stock awards.
Rankings
In 2020, Nikhil Lalwani's compensation ranked 3,117th out of 13,090 executives tracked by ExecPay. In other words, Lalwani earned more than 76.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,117 out of 13,090 | 76th |
Division Manufacturing | 1,212 out of 5,621 | 78th |
Major group Chemicals And Allied Products | 462 out of 2,254 | 80th |
Industry group Drugs | 400 out of 1,954 | 80th |
Industry Pharmaceutical Preparations | 299 out of 1,459 | 80th |
Source: SEC filing on April 29, 2021.
Lalwani's colleagues
We found five more compensation records of executives who worked with Nikhil Lalwani at ANI Pharmaceuticals in 2020.
2020
Stephen Carey
ANI Pharmaceuticals
Chief Financial Officer
2020
Robert Schrepfer
ANI Pharmaceuticals
Former Senior Vice President, New Business Development and Specialty Sales
2020
James Marken
ANI Pharmaceuticals
Senior Vice President, Operations and Product Development
2020
Patrick Walsh
ANI Pharmaceuticals
Chief Executive Officer
2020
Arthur Przybyl
ANI Pharmaceuticals